These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37772282)

  • 1. Safety and Efficacy of Long-Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open-Label Extension Study.
    Jankovic J; Coffey B; Claassen DO; Jimenez-Shahed J; Gertz BJ; Garofalo EA; Stamler DA; Wieman M; Savola JM; Harary E; Alexander J; Barkay H; Gordon MF
    Mov Disord Clin Pract; 2023 Sep; 10(9):1388-1398. PubMed ID: 37772282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.
    Coffey B; Jankovic J; Claassen DO; Jimenez-Shahed J; Gertz BJ; Garofalo EA; Stamler DA; Wieman M; Savola JM; Gordon MF; Alexander JK; Barkay H; Harary E
    JAMA Netw Open; 2021 Oct; 4(10):e2129397. PubMed ID: 34661664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial.
    Jankovic J; Coffey B; Claassen DO; Jimenez-Shahed J; Gertz BJ; Garofalo EA; Stamler DA; Wieman M; Savola JM; Gordon MF; Alexander J; Barkay H; Harary E
    JAMA Netw Open; 2021 Oct; 4(10):e2128204. PubMed ID: 34609495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deutetrabenazine in Tics Associated with Tourette Syndrome.
    Jankovic J; Jimenez-Shahed J; Budman C; Coffey B; Murphy T; Shprecher D; Stamler D
    Tremor Other Hyperkinet Mov (N Y); 2016; 6():422. PubMed ID: 27917309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.
    Bogan RK; Foldvary-Schaefer N; Skowronski R; Chen A; Thorpy MJ
    CNS Drugs; 2023 Apr; 37(4):323-335. PubMed ID: 36947322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome.
    Gilbert DL; Budman CL; Singer HS; Kurlan R; Chipkin RE
    Clin Neuropharmacol; 2014; 37(1):26-30. PubMed ID: 24434529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
    Cui YH; Zheng Y; Yang YP; Liu J; Li J
    J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study.
    Hauser RA; Barkay H; Fernandez HH; Factor SA; Jimenez-Shahed J; Gross N; Marinelli L; Wilhelm A; Alexander J; Gordon MF; Savola JM; Anderson KE
    Front Neurol; 2022; 13():773999. PubMed ID: 35280262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effectiveness of Aripiprazole for Tics, Social Adjustment, and Parental Stress in Children and Adolescents with Tourette's Disorder.
    Wang LJ; Chou WJ; Chou MC; Gau SS
    J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):442-8. PubMed ID: 27028456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapist-Supported Internet-Delivered Exposure and Response Prevention for Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial.
    Andrén P; Holmsved M; Ringberg H; Wachtmeister V; Isomura K; Aspvall K; Lenhard F; Hall CL; Davies EB; Murphy T; Hollis C; Sampaio F; Feldman I; Bottai M; Serlachius E; Andersson E; Fernández de la Cruz L; Mataix-Cols D
    JAMA Netw Open; 2022 Aug; 5(8):e2225614. PubMed ID: 35969401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot Study to Evaluate Pimavanserin for the Treatment of Motor and Behavioral Symptoms of Tourette Syndrome.
    Billnitzer A; Jankovic J
    Mov Disord Clin Pract; 2021 Jul; 8(5):694-700. PubMed ID: 34307741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders.
    Jakubovski E; Pisarenko A; Fremer C; Haas M; May M; Schumacher C; Schindler C; Häckl S; Aguirre Davila L; Koch A; Brunnauer A; Cimpianu CL; Lutz B; Bindila L; Müller-Vahl K
    Front Psychiatry; 2020; 11():575826. PubMed ID: 33324255
    [No Abstract]   [Full Text] [Related]  

  • 13. Symptoms compatible with long COVID in an Italian pediatric cohort of Tourette patients with and without SARS‑CoV‑2 infection: a short-term follow-up assessment.
    Prato A; Salerno AM; Saia F; Maugeri N; Zanini A; Scerbo M; Barone R; Rizzo R
    BMC Pediatr; 2023 May; 23(1):222. PubMed ID: 37147589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study.
    Cubo E; Fernández Jaén A; Moreno C; Anaya B; González M; Kompoliti K
    Clin Ther; 2008 Jan; 30(1):182-9. PubMed ID: 18343255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plum-blossom needle therapy for Tourette syndrome: A case report.
    Lin HZ; Yue Yang ; Yu JN
    Explore (NY); 2024; 20(3):456-459. PubMed ID: 37783584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life events and Tourette syndrome.
    Steinberg T; Shmuel-Baruch S; Horesh N; Apter A
    Compr Psychiatry; 2013 Jul; 54(5):467-73. PubMed ID: 23219489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical development of valbenazine for tics associated with Tourette syndrome.
    Farber RH; Angelov A; Kim K; Carmack T; Thai-Cuarto D; Roberts E
    Expert Rev Neurother; 2021 Apr; 21(4):393-404. PubMed ID: 33682568
    [No Abstract]   [Full Text] [Related]  

  • 18. A proprietary herbal medicine (5-Ling Granule) for Tourette syndrome: a randomized controlled trial.
    Zheng Y; Zhang ZJ; Han XM; Ding Y; Chen YY; Wang XF; Wei XW; Wang MJ; Cheng Y; Nie ZH; Zhao M; Zheng XX
    J Child Psychol Psychiatry; 2016 Jan; 57(1):74-83. PubMed ID: 26072932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial.
    Singer HS; Wendlandt J; Krieger M; Giuliano J
    Neurology; 2001 Mar; 56(5):599-604. PubMed ID: 11245709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.
    Müller-Vahl KR; Schneider U; Prevedel H; Theloe K; Kolbe H; Daldrup T; Emrich HM
    J Clin Psychiatry; 2003 Apr; 64(4):459-65. PubMed ID: 12716250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.